Captopril and Exenatide: Interaction Details
- Exenatide
- BydureonByetta
- Captopril
- Capoten
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Captopril and Exenatide interaction:
Exenatide
- Bydureon
- Byetta
We don't have a drug information page for Exenatide yet. Have a question about Exenatide? Ask a pharmacist, free →
What Happens When You Take Captopril With Exenatide
What can happen when they are taken together (rated Moderate)
An increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
The risk of hypoglycemia may rise when antidiabetic agents are given together with .123 Where combined therapy cannot be avoided, blood glucose should be checked more often, not only while the ACE inhibitor is being taken but also once it has been discontinued.4
Adjusting the insulin dose may likewise prove necessary.12 According to findings from a self-controlled case series, taking ACE inhibitors alongside insulin secretagogues does not appear to be linked to higher rates of serious hypoglycemia, although glimepiride may be an exception.5
The Captopril and Exenatide Interaction, Explained
Exenatide (Byetta, Bydureon) helps lower your blood sugar, and captopril (Capoten) is a blood pressure medicine. Some reports suggest that blood pressure medicines like captopril may make the body a bit more sensitive to diabetes medicines. That could slightly raise the chance of low blood sugar.
This concern is mostly theoretical, so there's no need to worry. Know the signs of low blood sugar, like shakiness, sweating, a fast heartbeat, confusion, or sudden hunger. Your care team may simply have you check your blood sugar more often. Keep taking both as prescribed, and talk with your pharmacist or doctor if you have questions.
Interaction: (captopril) with antidiabetic agents (exenatide) may increase the risk of . The mechanism is unknown. A proposed explanation is ACE inhibitor-mediated enhancement of insulin sensitivity (possibly bradykinin-related). This is a effect, not a PK one. No change in exenatide exposure is expected.
- Severity: moderate. Onset: unspecified. Evidence: theoretical.
- Self-controlled case series data show no increase in serious hypoglycemia with ACE inhibitors plus insulin secretagogues (possible exception: glimepiride). Exenatide alone carries low intrinsic hypoglycemia risk.
- Management: increase glucose monitoring during therapy and after ACE inhibitor withdrawal. Adjust concurrent insulin doses if needed.
See the 5 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Captopril and Exenatide Interact
The likely mechanism
Unknown
“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.
When two medicines can each cause the same effect, here changes in blood sugar, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.
How to Manage the Captopril and Exenatide Interaction
This combination is commonly used and can be managed safely. Here is what usually happens:
- Your care team may ask you to check your blood sugar more often, both while taking captopril and if it is ever stopped.
- If you also use insulin, its dose may need to be adjusted and individualized by your care team.
- Keep taking both medicines as prescribed.
- Tell your pharmacist or prescriber if you notice low blood sugar signs (shakiness, sweating, confusion) or frequent low readings.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Captopril or Exenatide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Angiotensin-converting enzyme inhibitors used concomitantly with insulin secretagogues and the risk of serious hypoglycemia
A self-controlled case series examined Medicare claims data from 5 states covering 1999 to 2011 to evaluate the of with insulin secretagogues (glimepiride, glipizide, glyburide, nateglinide, and repaglinide) or with metformin (negative control). The measured outcome was hospital presentation for serious .
Over the observation period, the number of serious hypoglycemic events was 8159 for glimepiride, 14,353 for glipizide, 11,129 for glyburide, 1595 for nateglinide, 2901 for repaglinide, and 32,639 for metformin. The confounder-adjusted rate ratio (RR) showed no significant elevation with glipizide, glyburide, repaglinide, or metformin; however, it was slightly elevated with glimepiride (RR, 1.23; 95% CI, 1.11 to 1.37) and slightly reduced with nateglinide (RR, 0.73; 95% CI, 0.56 to 0.96). Except for glimepiride, these findings suggest that concomitant use of an ACE inhibitor and insulin secretagogues was not associated with an increased risk of serious hypoglycemia.5
Captopril and Exenatide: Common Questions
How serious is the Captopril and Exenatide interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Captopril and Exenatide interaction managed?
This combination is commonly used and can be managed safely. Here is what usually happens: Your care team may ask you to check your blood sugar more often, both while taking captopril and if it is ever stopped. If you also use insulin, its dose may need to be adjusted and individualized by your care team. Keep taking both medicines as prescribed. Tell your pharmacist or prescriber if you notice lo… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Captopril and Exenatide Interaction
Ask in your own words about taking Captopril and Exenatide together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (5)
- Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
- Product Information: AFREZZA(R) oral inhalation powder, insulin human oral inhalation powder. MannKind Corporation(TM) (per manufacturer), Danbury, CT, 2014. DailyMed
- Product Information: Zestril(R) oral tablets, lisinopril oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2014. DailyMed
- Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
- Hee Nam Y, Brensinger CM, Bilker WB, et al: Angiotensin-converting enzyme inhibitors used concomitantly with insulin secretagogues and the risk of serious hypoglycemia. Clin Pharmacol Ther 2022; 111(1):218-226. PubMed
Other Serious Interactions of Captopril and Exenatide
Also serious with Exenatide
Also serious with Captopril
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Exenatide
- Siberian CockleburMajor
- ChromiumModerate
- GingerModerate
- TurmericModerate
- InositolModerate
- AshwagandhaModerate
- Black PepperModerate
- GinkgoModerate
- + 232 more
With Captopril
- Activated CharcoalMajor
- American HelleboreMajor
- American MistletoeMajor
- AsarabaccaMajor
- Siberian CockleburMajor
- TyramineMajor
- Vitamin B6Moderate
- SodiumModerate
- + 158 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.